Effect of a selective SGLT2 inhibitor, luseogliflozin, on circadian rhythm of sympathetic nervous function and locomotor activities in metabolic syndrome rats - Rahman, A; Fujisawa, Y; Nakano, D (J Clin Exp Pharmacol Physiol, 2017)
et al.